Pfizer agreed on Monday to combine its off-patent drugs division, which sells treatments like the cholesterol drug Lipitor, with the pharmaceutical company Mylan, creating a potential powerhouse in the increasingly challenging business of producing generic medicines.
Read more : https://www.nytimes.com/2019/07/29/business/dealbook/pfizer-mylan-deal.html
Carolina Partners Clinical Research Institute, a leading outpatient mental and behavioral health practice in North Carolina, and research firm Elligo Health Research, announced a partnership that will expand Carolina Partners' clinical research business, starting with its Situs Court location in Raleigh, North Carolina.
Read more : https://www.behavioral.net/news-item/carolina-partners-clinical-research-institute-elligo-announce-partnership
Meridian Clinical Research, LLC, based in Omaha, NE, has acquired the assets and operations of Regional Clinical Research, Inc., expanding its North American footprint to more than 20 investigative sites.
Read more : https://www.benzinga.com/pressreleases/19/07/n14110981/meridian-clinical-research-acquires-regional-clinical-research-of-new-york
Celltrion said this week it created a joint venture company in order to pursue the commercialization of 3 biosimilars in China. Celltrion formed Vcell Healthcare Limited with Nan Fung Group; Vcell also signed a licensing agreement with Celltrion.
Read more : https://www.centerforbiosimilars.com/news/celltrion-forms-joint-venture-to-sell-3-biosimilars-in-china
MinterEllison has advised on the merger of Arrow Pharmaceuticals and Apotex Australia to form Arrotex Holdings Pty Ltd (Arrotex).
Read more : https://www.australasianlawyer.com.au/news/minterellison-acts-on-major-pharma-merger-264563.aspx